Shanghai INT Medical Instruments Co (HKSE:01501) Risk Assessment

View and export this data going back to 2019. Start your Free Trial

What is Shanghai INT Medical Instruments Co Risk Assessment?

Risk Assessment represents the investment risk of a stock derived from our exclusive method. It suggests how risky the investment opportunity is based on the valuation and the fundamental performance of the stock. It is derived from following key aspects:

1. GuruFocus internally developed valuations of the stock, such as GF valuation.
2. Quality Rank, a business quality indicator developed by GuruFocus.
3. Fundamental performance: Piotroski F-Score, Altman Z-Score, Beneish M-Score, etc.
4. Growth opportunities: 5-year revenue growth rate, 5-Year EPS without NRI Growth Rate, etc.

Value investors are always willing to find undervalued stocks. However, not all the undervalued stocks are good deals, we should also be careful of how risky the investment opportunity is. We believe that if the company's financial strength and profitability are strong, and the stock price is within a reasonable range of the GF valuation, or stock has a high return with its price being undervalued, then it might be a good investment opportunity with low risk.

Based on those aspects listed above, GuruFocus believes the risk assessment of Shanghai INT Medical Instruments Co is: Low Risk: Strong fundamentals, worth long-term holding.

Competitive Comparison of Shanghai INT Medical Instruments Co's Risk Assessment

For the Medical Instruments & Supplies subindustry, Shanghai INT Medical Instruments Co's Risk Assessment, along with its competitors' market caps and Risk Assessment data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Shanghai INT Medical Instruments Co's Risk Assessment Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Shanghai INT Medical Instruments Co's Risk Assessment distribution charts can be found below:

* The bar in red indicates where Shanghai INT Medical Instruments Co's Risk Assessment falls into.

Shanghai INT Medical Instruments Co (HKSE:01501) Risk Assessment Explanation

Based on the four aspects listed above, GuruFocus provides the following 7 evaluations:

All-in-One Screener Examples (1)
Low Risk: Strong fundamentals, worth long-term holding
Moderate Risk: Sensitive, better choose undervalued stock
High Risk: High uncertainty with risk-return tradeoff
High Risk: Good fundamentals, beware of shrinking business
High Risk: Sensitive to economic or industry trends
High Risk: High uncertainty
No Data: Cannot be evaluated

(1) These are some simple examples. You can access our Risk Assessment filter under All-in-One Screener’s Fundamental tab and set your own criteria.

Shanghai INT Medical Instruments Co Risk Assessment Related Terms

Thank you for viewing the detailed overview of Shanghai INT Medical Instruments Co's Risk Assessment provided by GuruFocus.com. Please click on the following links to see related term pages.

Shanghai INT Medical Instruments Co (HKSE:01501) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Shanghai INT Medical Instruments Co Ltd (HKSE:01501) » Definitions » Risk Assessment

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 925 Jin Yuan Yi Road, Block 2, Jiading District, Shanghai, CHN, 201803

Website

https://www.kdl-int.com

Shanghai INT Medical Instruments Co Ltd formerly Shanghai Kindly Medical Instruments Co Ltd is a manufacturer of cardiovascular interventional devices, which are mainly used in cardiovascular surgeries, and in particular, PCI procedures in China. It is engaged in the sales, manufacture, research, and development of cardiovascular interventional medical devices as well as related accessories and molds. It is also engaged in the research and development of other interventional and implantable medical devices, such as neurological interventional medical devices and endocardia implantable medical devices, among others. Geographically, it has operations in Mainland China, Europe, the United States, and Other countries.

Executives

China Orient Asset Management (international) Holding Limited	2201 Interest of corporation controlled by you
Jpmorgan Chase & Co.	2106 Person having a security interest in shares
Zhao Wei	2202 Interest of your spouse
Ningbo Huaige Gongxin Equity Investment Partnership (limited Partnership)	2201 Interest of corporation controlled by you
Ningbo Huaige Health Investment Management Partnership (limited Partnership)	2201 Interest of corporation controlled by you
Ningbo Huaige Taiyi Equity Investment Partnership (limited Partnership)	2101 Beneficial owner
Wang Kai	2201 Interest of corporation controlled by you
Zhao Wei	2202 Interest of your spouse
Shanghai Gongye Investment Co., Ltd.	2201 Interest of corporation controlled by you
Zhang Wei	2501 Other
Worldwide Healthcare Trust Plc	2101 Beneficial owner
Orbimed Capital Llc	2102 Investment manager
Zheng Aiping	2501 Other
Zhang Xianmiao	2501 Other
Zhang Wei	2501 Other

Shanghai INT Medical Instruments Co (HKSE:01501) Headlines

No Headlines